Nurse Practitioner · Lafayette, LA
NPI
1215347182
Since 2014
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
2390 W Congress St
Lafayette, LA, 70506
Phone (337) 261-6545
Groups this clinician bills Medicare through
Medicare paid, 2024
$34K
503 services
Medicare patients, 2024
221
Average age 74
Drug cost, 2024
$3.0M
948 prescriptions
Company payments, 2025
$1,589
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kellie West was code 99215 (office e&m - established), 269 times for 67 patients. In total Kellie West billed 503 services in 5 codes, and Medicare paid $34K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-03-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 269 | 67 | $84.37 | $23K |
| 99214 Office E&M - Established | Facility | 168 | 128 | $52.05 | $8,744 |
| 99213 Office E&M - Established | Facility | 46 | 41 | $37.46 | $1,723 |
| 99213 Office E&M - Established | Office | 17 | 11 | $50.37 | $856 |
By year: 2022 $27K for 382 services; 2023 $36K for 561 services; 2024 $34K for 503 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kellie West prescribed most often to Medicare patients was Anastrozole, with 90 prescriptions and refills. In total Kellie West wrote 948 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 90 | 140 | 12 | $1,084 |
| Letrozole Generic | 86 | 177 | 25 | $1,533 |
| Hydroxyurea Generic | 50 | 92 | 13 | $1,610 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 42 | 42 | 11 | $848 |
| Gabapentin Generic | 37 | 48 | 12 | $441 |
| Escitalopram Oxalate Generic | 28 | 44 | Under 11 | $213 |
| Imbruvica Ibrutinib | 27 | 27 | Under 11 | $433K |
| Oxycodone Hcl Generic | 26 | 26 | Under 11 | $812 |
| Calquence Acalabrutinib Maleate | 25 | 25 | Under 11 | $376K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 24 | 24 | Under 11 | $315 |
| Imatinib Mesylate Generic | 23 | 23 | Under 11 | $50K |
| Levothyroxine Sodium Generic | 21 | 37 | Under 11 | $146 |
| Revlimid Lenalidomide | 20 | 20 | Under 11 | $291K |
| Morphine Sulfate Er Morphine Sulfate | 20 | 20 | Under 11 | $790 |
| Xarelto Rivaroxaban | 19 | 23 | Under 11 | $13K |
Brand drugs: 259 claims; generic drugs: 689 claims; opioid claims: 125.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kellie West $1,589 ($1,589 in general payments such as food, travel and fees) from 28 companies. The largest payer was Novartis Pharmaceuticals Corporation with $333.
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation NVS | 13 | $333 |
| Pfizer Inc. PFE | 7 | $147 |
| AstraZeneca Pharmaceuticals LP AZN | 6 | $104 |
| Janssen Biotech, Inc. JNJ | 4 | $95.34 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $92.99 |
| Abbvie Inc. ABBV | 4 | $80.69 |
| Daiichi Sankyo Inc. 4568.T | 3 | $70.31 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 3 | $64.19 |
| E.R. Squibb & Sons, L.L.C. BMY | 3 | $56.32 |
| Array Biopharma Inc PFE | 3 | $48.89 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.